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PAIRED (PRD)-like homeobox genes belong to a class of predicted transcription factor genes. Several of 
these PRD-like homeobox genes have been predicted in silico from genomic sequence but until recently 
had no evidence of transcript expression. We found recently that nine PRD-like homeobox genes, 
ARGFX, CPHX1, CPHX2, DPRX, DUXA, DUXB, NOBOX, TPRX1 and TPRX2, were expressed in human 
preimplantation embryos. In the current study we characterized these PRD-like homeobox genes in 
depth and studied their functions as transcription factors. We cloned multiple transcript variants from 
human embryos and showed that the expression of these genes is specific to embryos and pluripotent 
stem cells. Overexpression of the genes in human embryonic stem cells confirmed their roles as 
transcription factors as either activators (CPHX1, CPHX2, ARGFX) or repressors (DPRX, DUXA, TPRX2) 
with distinct targets that could be explained by the amino acid sequence in homeodomain. Some PRD-
like homeodomain transcription factors had high concordance of target genes and showed enrichment 
for both developmentally important gene sets and a 36 bp DNA recognition motif implicated in Embryo 
Genome Activation (EGA). Our data implicate a role for these previously uncharacterized PRD-like 
homeodomain proteins in the regulation of human embryo genome activation and preimplantation 
embryo development.
Human preimplantation development, starting with the fusion of egg and sperm and continuing to blasto-
cyst implantation1 is characterized by drastic changes in gene expression, especially a massive degradation of 
oocyte transcripts and a gradual, cascade-like initiation of transcription from the embryo genome2,3. The cellu-
lar factors responsible for the Embryo Genome Activation (EGA) have not been fully characterized. However, 
recently the PRD-like homeodomain transcription factors were implicated in human EGA and preimplantation 
development3.
The PRD-like homeobox genes form one of several classes of homeobox genes4. Homeobox genes are evo-
lutionarily conserved and the majority of these genes are critical for the regulation of development5. Examples 
of homeobox genes include the HOX cluster genes6 that are known to play key roles in cell fate determination 
and cell differentiation. Homeobox genes are relatively well characterized in several model organisms, especially 
in Drosophila melanogaster, and several of the PRD-like homeobox genes have previously been suggested to be 
expressed in the human germline7. The PRD-like homeobox genes share a similar homeodomain, but they lack 
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the actual PRD domain4. The homeodomain consists of approximately 60 amino acid (aa) residues and folds 
into a N-terminal arm and three alpha-helices8. The N-terminal arm and the third helix have been implicated in 
DNA-binding specificity and DNA-sequence recognition9.
Our recent study on human preimplantation development revealed the expression of 14 PRD-like homeodo-
main transcription factors during EGA, and we validated the presence of seven factors by cDNA cloning3. Most of 
these transcription factors had been predicted7,10, but only a few had been validated on transcript level11.
Here we describe the molecular cloning of several new splice variants for altogether nine human PRD-like 
homeobox genes, ARGFX (arginine-fifty homeobox; altogether six splice variants), CPHX1 (cytoplasmic polyade-
nylated homeobox 1), CPHX2 (cytoplasmic polyadenylated homeobox 2; three splice variants), DPRX (diver-
gent paired-related homeobox; two splice variants), DUXA (double homeobox A), DUXB (double homeobox B; 
three splice variants), TPRX1 (tetra-peptide repeat homeobox 1), TPRX2 (tetra-peptide repeat homeobox 2; three 
splice variants) and NOBOX (NOBOX oogenesis homeobox). We show the first evidence of TPRX2P expression 
and propose that it should be renamed TPRX2 as previously suggested7. Many of these PRD-like homeobox genes 
appeared primate specific, expressed at very low levels in most tissues and restricted to preimplantation devel-
opment. Experimental overexpression of the PRD-like homeodomain transcription factors in human embryonic 
stem cells (hESCs) reveals target genes that intersect with a significant number of the genes first activated in 
human embryos. The target gene promoters are enriched for the 36 bp motif previously predicted to play a major 
role in human EGA3.
Results
Cloning of PRD-like homeobox genes from human 8-cell stage embryos. Our previous transcrip-
tion start site (TSS) enriched data on human preimplantation embryos suggested unannotated transcripts for 
ARGFX, CPHX1, CPHX2, DPRX, DUXA and DUXB3. Furthermore, two highly similar Tprx family genes TPRX1 
and TPRX2 were predicted. We described previously the cDNA cloning of a major splice form for ARGFX, 
CPHX1, CPHX2, DPRX, DUXA and DUXB3. In the present study, we cloned novel splice variants of NOBOX, 
TPRX1 and TPRX2 together with additional splice variants for the ARGFX, CPHX2, DPRX and DUXB genes from 
human 8-cell embryos.
We amplified and cloned transcripts for each gene by PCR from non-sheared full-length cDNA libraries of 
three whole 8-cell embryos prepared according to the sequencing library preparation protocol by Tang et al.12. 
The validated transcripts are visualized in Fig. 1 and in UCSC Genome Browser views in Supplemental Figure S1 
Figure 1. Exon-intron structure of PRD-like homeobox genes. Exons are drawn to scale and represented 
by horizontal boxes. 5′ and 3′ UTRs are shown as thinner boxes, protein coding region as thicker boxes with 
homeobox sequence colored grey. Introns are represented by solid lines. Chromosomal locations and Gene 
IDs, if available, are given on the right. * Indicates the isoform used in the overexpression experiment. NA, not 
available.
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together with previously predicted gene sequences and the cloning primer locations. Forward primers were 
designed on the TSS sequences, and reverse primers by predicted gene structures and low level downstream 
reads (exon painting). The full gene names, references, identifiers, cloning primers and clone origins are shown 
in Table 1. The sequences for ARGFX, DPRX, DUXA and DUXB had been previously suggested7,10, but only 
ARGFX had been confirmed experimentally11. NOBOX was amplified from cDNA that was reverse transcribed 
from commercially available poly-A enriched human ovary RNA. The partial transcript sequence for NOBOX had 
been previously validated by cDNA cloning13, and two additional synthetic constructs are presented in GenBank 
(BC152834 and AB528776). Current RefSeq annotation follows the structure of the synthetic constructs for exons 
1–8 (Supplementary Figure S2). However, our data suggested a novel intronic TSS resulting in a novel tran-
script with novel first exon, lacking exons number 1–4 and a shortened exon 5 compared to the RefSeq variant 
(Supplementary Figure S2). The longer exon 5 of the RefSeq variant disrupts the homeodomain, which is encoded 
by exons 1–3 of our new transcript variant. Our predicted homeodomain structure, however, corresponded to 
that previously presented13.
Three genes, CPHX1, DUXB and CPHX2 form a gene cluster on 16q23.1 within a 68 kb segment on the same 
strand (chr16:75,693,001–75,761,000) (Supplemental Figure S3). These genes are currently lacking genome anno-
tation, even though they have been predicted in human based on syntenic genomic location between human and 
mouse14. The alignment of amino acids between human CHPX1 and CPHX2 confirms high sequence conserva-
tion also outside the homeodomain (Supplemental Figure S4a).
CPHX2 amplification produced three different splice variants, two of which contained exons 1, 2, and variably 
exon 3, and one splice variant lacking exon 2. Different open reading frames (ORF) were predicted for each three 
splice variants, with only one having a complete homeodomain (Fig. 1).
The PCR amplification using the TPRX1 (Gene ID: 284355) TSS as a primer led to the discovery of TPRX1 
itself from one 8-cell embryo, but in addition three additional splice variants of TPRX2P from three independ-
ent 8-cell embryos. TPRX2P is closely related to TPRX1 located 18.3 kb away at chr19:48,307,772–48,307,835. 
TPRX2P was previously annotated as a pseudogene but proposed to be named TPRX2 if shown to be expressed7. 
Therefore, we suggest to rename TPRX2P as TPRX2. All TPRX2 variants included three exons of variable lengths, 
but only the longest splice variant encoded a full homeodomain (Fig. 1). The amino acid sequence alignment 
between TPRX1 and TPRX2 showed high similarity of the first 140 amino acids including the homeodomain 
(Supplementary Figure S4b).
The PCR amplification revealed a single splice variant for CPHX1, DUXA and NOBOX, all encoding for at 
least one full homeodomain. Only one of the two validated DPRX transcripts encoded for full homeodomain. 
ARGFX amplification gave two splice variants with the predicted ORF consistent with gene model and four addi-
tional splice variants (Fig. 1). Amplification of DUXB resulted in three amplicons of which only the longest was 
predicted to contain both homeodomains.
The most likely functional splice variant containing the full-length homeodomain sequence and observed 
in all three independent 8-cell embryo libraries is marked in Fig. 1 with an asterisk. These isoforms were subse-
quently used in the hESC overexpression experiment. The genomic locations of the PRD-like homeobox genes 
are shown in Supplementary Figure S5.
Expression of PRD-like homeobox genes in early embryos and pluripotent stem cells. To inves-
tigate the developmental specificity of PRD-like homeobox gene expression, we used single cell RNA sequencing 
(RNAseq) on single blastomeres from two 8-cell stage embryos and two different hESC lines15 and compared the 
expression patterns (Fig. 2).
Gene name
Full name & first 
reference Gene ID TFE ID* TFE Region Strand Forward/Reverse Primer Clone origin
ARGFX arginine-fifty homeobox7 503582 FE367949
chr3:121286750–










FE200054 chr16:75710885–75711065 − GAGTTTCGACATGTCTTCCCAAG/TGACCTGTGGCTATGGTTCTGT 8-cell embryo
DPRX divergent paired-related homeobox7 503834 FE273734
chr19:54135194–
54135433 + TATCCCTGGACCTGAACCCA/ACACATCATTACAACATGTGACT 8-cell embryo
DUXA double homeobox A7 503835 FE262918
chr19:57678787–
57678897 − GCTCAGCCTTCAGGACTCTCT/GTGAGACAGATTTGGGGTCCA 8-cell embryo
DUXB double homeobox B10 100033411 FE200082
chr16:75735289–
75735420 − TTACTCGCTGATCTCCGTGG/TCAGCTGAGTGTGCCTACTG 8-cell embryo
NOBOX NOBOX oogenesis homeobox13,27 135935 FE518599
chr7:144100745–
144100865 − ATGGAACCCACAGAGAATCC/ACAAGACGAGCCTACACAGG Ovary
TPRX1 Tetra-peptide repeat homeobox 17 284355
chr19:48307780–
48307850 − TCAGGACTCAGGATGCAAGAC/ATCCCAGCAGAGAAACGCTC 8-cell embryo
TPRX2 tetra-peptide repeat homeobox 27 503627
chr19:48362000–
48363000 + TCAGGACTCAGGATGCAAGAC/ATCCCAGCAGAGAAACGCTC 8-cell embryo
Table 1.  Cloning of PRD-like homeobox genes. * TFE, Transcript far 5′ end, TFE ID refers to TSS data by 
Töhönen&Katayama, et al.13.
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In concordance with our previous results3, we detected the expression of ARGFX, CPHX1, CPHX2, DPRX, 
DUXA, DUXB, NOBOX, TPRX2 and OTX2 in single blastomeres from 8-cell stage embryos. OTX2 was included 
as a positive control gene representing a previously characterized PRD-like homeobox gene. CPHX1, DPRX, 
DUXA, DUXB, and OTX2 expression was detected in all blastomeres with highest expression levels for DUXA 
and OTX2. ARGFX and CPHX2 expression was detected in the majority of blastomeres. NOBOX and TPRX2 
expression was detected in one and four single blastomeres, respectively. The largest variation in expression levels 
among the different blastomeres was detected for ARGFX and DPRX, whereas DUXA and DUXB expression was 
at similar levels for all blastomeres.
In contrast to the expression of PRD-like homeobox genes in blastomeres, the expression in hESCs was much 
lower. Thus, CPHX1, CPHX2, DUXB, NOBOX and TPRX2 expression was not detected in any of the two different 
hESC lines (Fig. 2). Both ARGFX and DPRX expression was detected in only three or one single cell, respectively. 
Only DUXA and OTX2 were readily detectable in the hESCs, albeit only in a subset of the cells. DUXA was 
detected in seven out of 15 HS983a cells and in two out of 15 HS980 cells. The positive control OTX2 was detected 
Figure 2. Expression of PRD-like homeobox genes in 8-cell blastomeres and hESCs. STRT RNAseq 
expression values are shown for two 8-cell stage blastomeres (14 single cells in total) and for two different hESCs 
(HS980 and HS983a, 15 single cells each) at single cell resolution. Each dot indicates a single cell: 8-cell (filled 
circle), hES cell line HS983a (not filled circle) or hES cell HS980 (star). Y-axis shows log10 transformed spike-in 
normalized expression values. Vertical line indicates mean values. ND, not detected, indicates the number of 
cells in which the gene of interest was not detectable over the total number of cells analyzed with the threshold 
of one sequencing read per cell.
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in 12 out of 15 cells from both hESC lines. The expression levels detected in the hESCs were lower than that for 
human single blastomeres for all PRD-like homeobox genes detected.
In order to independently confirm the developmental pattern of PRD-like homeobox gene expression, we 
applied PCR on an additional set of cDNA samples, including HS980 and whole 8-cell stage embryo libraries. 
In this manner, we detected only low levels of expression of ARGFX, CPHX1, DPRX, DUXA and DUXB in three 
hESC lines, including HS980 (Supplementary Figure S6).
The majority of cell types and tissues lack PRD-like homeobox gene expression. To investigate 
mRNA expression of the PRD-like homeobox genes in different cell types and tissues, we used the FANTOM5 
database16,17. Only OTX2 was shown to be expressed in the FANTOM5 database, whereas all the new genes were 
barely detectable in very few of the 1829 samples (Supplemental Table S1). Specifically, none of the new tran-
scripts had an annotated transcriptional start site (TSS) in FANTOM5 data. Only one unannotated promoter 
corresponded to one of our genes, namely the DUXB TSS, but it lacked correct annotation due to the fact that 
there was no annotation for DUXB itself in FANTOM5.
The lack of expression in FANTOM5 data suggested possible silencing of the genes in later stages of develop-
ment. To investigate methylation as a possible silencing mechanism of the PRD-like homeobox genes, we consid-
ered the DNA methylation status of their promoters in human sperm, preimplantation embryos and embryonic 
tissues18. Percentage of methylated CpG-s from around 1000 bp from the homeobox genes TSS was plotted for 
all the samples and replicas with sequencing coverage of at least 5x (Supplementary Figure S7). The results show 
hypomethylation for all the detected homeobox genes in preimplantation embryos compared to various ESC-s 
and embryonic tissues. This suggests a rapid epigenetic silencing mechanism after the preimplantation develop-
ment. The more widely expressed control gene OTX2 however was not similarly methylated in course of devel-
opment. Additionally we assessed the methylation status of these genes in blood cells19. The results show that in 
blood cells these genes were highly methylated, supporting the mechanism of epigenetic silencing in adult tissues 
(Supplementary Figure S8).
Overexpression of the PRD-like homeobox genes in hESC identifies target genes. We over-
expressed the PRD-like homeobox genes in hESC to identify their target genes. The pFastBac vector used con-
tained both the gene of interest and an eGFP fluorescent marker, enabling separation of transfected cells from 
non-transfected cells by Fluorescence Activated Cell Sorting (FACS). We could then verify the co-expression of 
the two proteins in the same cells by the simultaneous expression of eGFP and the red fluorescence gene mCherry 
control both by microscopy (Supplementary Figure S9a) and by FACS analysis (Supplementary Figure S9b). 
Successful sorting of the transfected versus non-transfected cells was further confirmed by mapping the sequenc-
ing reads to the original pFastBac vector backbone. The vast majority of reads from the GFP positive samples 
originated from the overexpression vector, while there were very few reads detected in the GFP negative samples 
(Supplementary Figure S9c).
After quality control and the exclusion of one disqualified GFP negative control sample, we performed the 
differential expression analysis as previously described20. We listed the differentially expressed TSSs from each 
comparison at p < 0.05, and for robustness, we considered for further analyses the intersection of lists against 
three control conditions. The analysis yielded 18 gene sets in total: upregulated and downregulated gene sets for 
all the PRD-like homeobox genes and the OTX2 control (Fig. 3a).
Among the regulated target genes we identified 12 common target genes that were either upregulated by at 
least four or downregulated by at least five of the different PRD-like homeodomain transcription factors. These 
12 common target genes included, among others, the cell-cycle gene NASP, the pluripotency associated gene 
DPPA3, the trophoblast determining gene KRT18, the pre-mRNA processing genes PRRC2C and SRSF11 and the 
homeodomain gene OTX2 itself (Fig. 3b).
Furthermore, there were some targets that were specific for a subset of the homeodomain genes. For example, 
three out of the four Yamanaka factors (KLF4, MYC, POU5F1, SOX2) were differentially regulated by TPRX2, 
OTX2, DUXA and DPRX: SOX2 was downregulated by TPRX2 and OTX2, MYC was downregulated by OTX2, 
DUXA and DPRX, and POU5F1 was upregulated by DPRX and downregulated by OTX2. Interestingly, CPHX1 
upregulated BCAP31 and USP9X, two genes important for gamete generation21.
The PRD-like homeodomain transcription factors may act both as activators and repres-
sors. The number of differentially expressed genes varied between the different PRD-like homeodomain 
transcription factors, with DPRX regulating the largest number of genes. The majority of DPRX target genes 
were downregulated and showed overlap with TPRX2 and ARGFX downregulated target genes (Fig. 3c). The 
smallest number of significantly regulated genes was found for DUXB. We found distinct roles for the PRD-like 
homeodomain genes as either mainly activators, such as ARGFX, CPHX1 and CPHX2 (Fig. 3a,c), or as mainly 
repressors, such as DPRX, DUXA and TPRX2 (Fig. 3a,c). For testing the application of our results to the con-
text of human embryos, we looked at the expression of up-regulated genes by the three activators (CPHX1, 
CPHX2 and ARGFX) in human embryos2. An independent RNA sequencing dataset from human embryos and 
ESC-s showed up-regulation of the target genes in the course of embryo development for all three activators 
(Supplementary Figure S10). Full lists of the target genes, their corresponding TSSs and genomic annotations are 
given in Supplementary Table S2.
To further investigate the target gene profiles, we performed cross-comparisons between all upregulated or 
downregulated genes. The significance of the overlap was evaluated by Chi-squared test statistic or Fisher’s exact 
test. A major overlap was found between the upregulated targets of CPHX1 and CPHX2 (p < 2 × 10−14) (Fig. 3d), 
and genes upregulated by DUXB and CPHX1 (p < 2 × 10−8), ARGFX and OTX2 (p < 2 × 10−5), and CPHX1 and 
NOBOX (p < 2 × 10−5).
www.nature.com/scientificreports/
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In the same manner, the comparison between downregulated target genes yielded a number of significant 
overlaps; the target genes downregulated by DPRX, TPRX2, DUXB and NOBOX all have significant overlap 
between each other (Fig. 3c). Furthermore, DPRX and ARGFX share a significant number of downregulated 
target genes with all other PRD-like homeodomain genes except for CPHX1, CPHX2 (both) or DUXB (only 
ARGFX). We also tested the overlaps of the target genes upregulated by one factor and downregulated by another 
(Supplementary Figure S11). A significant overlap was observed between the downregulated targets of DPRX 
and upregulated targets of both CPHX1 (p < 2 × 10−8) and CPHX2 (p < 2 × 10−14). These data suggest tentative 
regulatory networks controlling human EGA.
Target gene profiles can be influenced by the amino acid sequence of the homeodomain. Since 
the members of the PRD-like homeobox gene family share similar amino acid sequences in the homeodomains 
(Fig. 3e), we hypothesized that they might target the same genes through similar DNA-binding properties. Thus, 
Figure 3. Target genes of the PRD-like homeobox genes in hESCs. The homeobox genes were overexpressed 
in hESCs followed by transcriptional profiling by RNAseq. (a) The number of up- and down-regulated target 
genes following transfection for 9–11 hours. (b) The most commonly occurring up- and down-regulated 
target genes are shown as a gene network. (c) Similarity of the down-regulated target gene lists as observed by 
performing chi-squared test to the pairwise overlap of all the gene sets. (d) Similarity of the up-regulated target 
genes lists as observed by performing chi-squared test to the pairwise overlap of all the gene sets. The color 
indicates logarithmic value of the chi-squared test statistics, and the significance of higher than expected  
overlap is shown by asterisk according to the multiple-testing corrected Fisher’s exact test value (p < 10−2* ,  
p < 5 × 10−5* * , p < 5 × 10−8* * * ). (e) Alignment of the amino acid sequences for all homeodomains in the 
CPHX1, CPHX2, ARGFX, DUXB, NOBOX, DUXA, TPRX2 and DPRX genes. Conserved residues are marked 
in blue, homeodomain helices have a green background. A conserved splice-site is marked by a red line. * Mark 
the position of variable amino acids in the DNA-binding domain that are indicated in (c,d). Dotted line around 
the amino acid stretch shows grouping of similar genes (c,d). The red line marks the splice site characteristic for 
PRD-like homeobox genes4,36.
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we correlated the observed overlaps of the target genes with sequence similarities of the homeobox domains 
(Fig. 3c,d).
CPHX1 and CPHX2 shared a large number of upregulated target genes (Fig. 3c), and they had an almost iden-
tical homeodomain, with only 4 aa difference (Fig. 3e). DUXA and DUXB differed from the others in having two 
homeodomains. Only DUXB had the residues V-KN-A, but both DUXA and DUXB shared a number of target 
genes with the others (Fig. 3d). ARGFX stood out with a different homeodomain sequence and significant over-
lap between its downregulated target genes and the target genes of DPRX, TPRX2, OTX2, DUXA and NOBOX. 
Comparing the overall homeodomain sequence, ARGFX shared 35% and 33% aa identity with DUXA, whereas 
the homeodomains in DUXB shared 33% and 28% aa identity with ARGFX. The same degree of aa identity in the 
homeodomain (35%) was seen between ARGFX and TPRX2. This shows that although the similarities in the DNA 
binding domain indicate similar target gene profiles, the homeodomain similarity was not alone determining the 
target gene expression profiles.
Target genes of PRD-like transcription factors are activated during human preimplantation 
development. We suggested earlier that the new PRD-like homeobox genes might act as key regulators of 
human early development3. In order to further test this hypothesis, we analyzed the overlap between the differen-
tially expressed target genes in our overexpression experiments and the genes upregulated at various stages of pre-
implantation development: EGA2,3, trophectoderm (TE), epiblast (EPI), primitive endoderm (PE) and inner cell 
mass (ICM)22 (Fig. 4). The similarity of targets was tested by Chi-squared test after matching the dataset-specific 
TSSs for EGA genes from Töhönen, et al. The lists of upregulated genes from Yan et al. and Blakeley et al. were 
calculated as described in materials and methods, and the Chi-squared test was performed by matching the gene 
names. The number of observed intersecting genes between the experimentally regulated gene sets and the pre-
implantation gene sets was calculated and compared with the expected number of intersecting genes occurring 
by chance. We report multiple testing corrected p-values.
Most of the comparisons with PE, ICM and EPI gene sets yielded no statistically significant overlaps with 
the experimental gene sets, except for OTX2. Eight target genes of OTX2 overlapped with ICM genes, while 
overlap of only 2 genes was expected (p = 0.012). Larger overlap than expected was noted for DPRX (110/72, 
p = 3.7 × 10−5) and TPRX2 (32/18, p = 0.045) with the TE genes. The most significant overlaps were observed 
for DPRX with both EGA datasets (Töhönen et al.3; 64/20, p = 5.5 × 10−25 and Yan et al.2; 64/24, p = 3 × 10−17).
Activity of the homeobox genes via DNA motif implicated in preimplantation development. 
The PRD-like homeobox genes were suggested to act on a motif found enriched in the promoters of EGA genes3. 
In order to test further the hypothesis, we studied the enrichment of the 36 bp embryo motif in the promoters 
of the experimental target genes (2000 bp upstream and 500 bp downstream from TSS) by the MAST software23. 
The results confirmed the enrichment of the 36 bp motif upstream of the TSS for genes regulated by most of 
the PRD-like homeobox genes (Fig. 5a). This result further strengthened the notion of the functionality of the 
Figure 4. Overlap of target genes with developmentally important gene sets. Chi-squared test was 
performed for identifying significant number of intersecting genes. Target genes from our overexpression 
experiment were compared to the developmentally important datasets of genes up-regulated in embryonic 
genome activation (EGA) (two independent datasets for EGA.Yan2 and EGA.Töhönen3), epiblast (Epi), 
Trophectoderm (TE) or inner cell mass (ICM)22. The number of observed divided by expected number of 
intersecting genes is indicated by color scale, and written on the plot followed by multiple-testing corrected 
p-value in brackets.
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predicted motif for PRD-like genes, and supported the 36 bp motif as a key regulatory element in human preim-
plantation development.
To further investigate the suggested main activators CPHX1, CPHX2 and ARGFX as transcription activators, 
we performed luciferase reporter assays after co-transfecting human embryonic kidney cells (HEK-293) with a 
transcription factor at a time and a reporter construct with ZSCAN4 promoter upstream of the luciferase gene. 
The ZSCAN4 promoter contained multiple repeats of the 36 bp motif, and ZSCAN4 was upregulated in EGA3. The 
ZSCAN4 promoter yielded up to 27 fold increase in luciferase expression when co-transfected with CPHX1, but 
not with CPHX2 or ARGFX, suggesting further specificity of function (Fig. 5b).
Discussion
The homeodomain proteins make up approximately 15–30% of all animal transcription factors24. A number of 
homeodomain proteins have been shown to be important for early development in vertebrate species25,26, and 
some homeodomain proteins are restricted in expression to specific cells at specific developmental stage. In our 
previous study we detected the expression of PRD-like homeobox genes expressed in oocytes, zygotes or single 
blastomeres from 4- and 8- cell embryos3. The transcript variants of the PRD-like homeobox genes ARGFX, 
CPHX1, CPHX2, DPRX, DUXA, DUXB, TPRX1 and TPRX2 cloned in this study may be expressed only during 
a restricted time period, explaining their recent discovery. A thorough investigation of human homeobox loci 
revealed that ARGFX, DPRX, TPRX1 and DUXA were initially predicted and annotated based on a few existing 
EST, retrotransposed pseudogene and genomic sequences7,10. Of the genes presented here only NOBOX was pre-
viously well characterized and found expressed at high levels in the ovary, specifically in primordial and growing 
oocytes27. Interestingly, our sequencing data indicated a new TSS yielding a novel splice variant of NOBOX that 
we confirmed by cDNA cloning. This novel NOBOX TSS had barely detectable expression in 4- or 8-cell embryos 
and embryonic stem cells.
In our database searches the PRD-like homeobox genes were undetectable in most cell types and tissues, 
including the comprehensive FANTOM5 database. In agreement with their absent expression, these genes were 
rapidly methylated in directly after preimplantation stage in human embryos18 , suggesting an epigenetic silencing 
mechanism (Supplementary Figure S7). This observation was also consistent with the commonly observed silenc-
ing of Alu elements enriched in the promoters of the new genes3,28. During human preimplantation development 
the DNA methylation levels are reset, which is critical for the normal development29,30.
Figure 5. Promoter properties of the homeodomain genes. (a) Enrichment of a 36 bp DNA motif in the 
promotor region (− 2,000 ~ + 500 bp distance around the center of the TFE) of the PRD-like homeodomain 
transcription factor target genes. The motif was enriched upstream of the promoters of genes during human 
pre-implantation development (red line). The motif is over-represented upstream of the up- and down-
regulated genes by homeobox genes and under-represented from about 0 to 500 bp downstream from the 
TFE position. The motif is not enriched in any specific regions among random start-sites from the FANTOM 
database (blue dotted line). (b) Luciferase expression Fold Change between ZSCAN4 promoter-containing 
vector and corresponding empty vector (pGL4.25) with transfection by activators CPHX1, CPHX2 and ARGFX 
in HEK293 cell lines. The average values from three biological replicas are shown, error bars represent standard 
deviation. The values are normalized to corresponding vector without transcription factor overexpression.
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Due to ethical reasons, functional studies in human embryos were not possible for these genes. However, we 
chose the closest and biologically most relevant cell line hESC-s for overexpression experiment. The PRD-like 
homeobox genes could induce both up- and downregulation of target genes based on the hESC overexpres-
sion experiment (Fig. 3a), and the target genes showed significant overlaps both between the different factors 
themselves (Fig. 3c,d) and between previously published human preimplantation data sets (Fig. 4). While the 
target genes show expected overlaps with published datasets from embryos, we have to acknowledge that some 
of the identified target genes might not be the same in human embryos due to the usage of cell model. Since 
the expression of PRD-like homeodomain transcription factors was very lowly or not at all detected in hESC-s 
(Supplementary Figure 6), some of the target genes in human embryos might not be overexpressed due to the 
cellular context such as due to methylation of the gene region.
In the hESCs, DPRX was found to downregulate the largest number of target genes (2067), followed by TPRX2 
(464) and DUXA (362). We propose that DPRX might be needed to restrict the expression of a number of acti-
vated genes after the EGA, allowing later lineage specification.
The luciferase reporter assay using a putative ZSCAN4 promoter placed upstream of the luciferase gene fur-
ther confirmed that CPHX1, but not the other activators CPHX2 and ARGFX acts on ZSCAN4 promoter (Fig. 5b). 
Thus the activity of these factors was not determined only by their homeodomain, but rather a combination of 
homeodomain specificity, possible transactivating domains in the protein or their cellular context and interaction 
with other proteins. For example, OTX2 has been shown to interact on protein level with LHX1 and FOXA231. 
Thus, the cellular context may affect the transcriptional activity of the PRD-like homeodomain proteins.
We studied the possibility that the overlap of target genes for the PRD-like homeobox genes might result from 
the similarities in the DNA-binding regions of their homeodomains. We observed a large number of genes upreg-
ulated by CPHX1 and CPHX2, and they differed in their homeodomain aa sequence at six positions only with a 
high overall protein sequence similarity (Supplementary Figure S4 a). ARGFX, on the other hand, only shared 17 
aa identity with the homeodomains of CPHX1 and CPHX2, possibly explaining the low overlap of target genes for 
these transcription factors even though all three seemed to function mainly as activators (Fig. 3c,d). As an exam-
ple, ZSCAN4, a known inducer of iPS cells32 was significantly upregulated by CPHX1 only. Further experimental 
evidence is needed in order to define the specificity of the target gene profiles of the homeodomain proteins.
It is known that an aa change at position 52 in the DNA-recognition part of the homeodomain in NOBOX 
may cause premature ovarian failure due to disruption of the transcription factor binding to the NOBOX-binding 
consensus sequence33. When aligning the different homeodomains for our 9 transcription factors we see that 
at position 52 the aa varies between the different factors. For example, ARGFX, OTX2, TPRX2 and DUXA have 
an arginine residue at position 52, just as NOBOX. The overall highly similar CPXH1 and CPXH2 differ at this 
position (lysine or asparagine).
PRD-like transcription factors have been implicated in early development in other organisms such as 
Drosophila melanogaster. For example, the Drosophila prd-like homeobox gene Odysseus is involved in germ 
cell formation34. Interestingly, we found that CPHX1 upregulates the expression of BCAP31 and USP9X, whereas 
CPHX2 upregulates SPIN3, all three genes involved in human gamete generation according to DAVID annota-
tion. In addition, BCAP31 is downregulated by DUXB and TPRX2. Also other germ cell related genes, such as 
ZFP42, TEX14 and TFAP2C were regulated in our overexpression experiment. Targets of the PRD-like homeodo-
main transcription factors were enriched in genes upregulated during early development (Fig. 4). OTX2 targets 
were enriched in ICM, TPRX2 targets in TE and DPRX targets in TE and EGA.
In conclusion, this study presents further evidence of expression for the nine PRD-like genes that we recently 
identified from human preimplantation embryos3. Our data support the hypothesis that the previously unchar-
acterized PRD-like homeobox genes are specifically expressed during early development, have a key role in the 
transcriptional dynamics during EGA, and are subsequently silenced as the development progresses from a pluri-
potent stage towards more highly differentiated stage.
Materials and Methods
Human embryos. Human embryos used in this study were collected in Sweden and donated by informed 
consent by couples who underwent infertility treatment by in vitro fertilization (IVF). Cryopreserved cells that 
were not needed for IVF treatment were donated as an alternative to being destroyed as they had exceeded the 
maximum legal storage time. Cleavage stage embryos were frozen at the 4-cell stage on day 2 after fertilization. 
After thawing, embryos were allowed to develop until the 8-cell stage in a sequential culture system (G1/CCM 
medium, Vitrolife at 37 °C and 5% CO2 and 5% O2). This study was reviewed and approved by the ethics review 
boards according to Swedish law (Dnr 2010/937-31/4 of the Regional Ethics Board in Stockholm). All the meth-
ods were carried out in accordance with the approved guidelines.
Library preparation. Human embryo libraries were prepared after thawing the embryos at the 4-cell stage 
and incubation allowing them to develop until the 8-cell stage. Each single embryo was put into a 0.5 mL PCR 
tube containing 4.45 μ l of freshly prepared cell lysis buffer and the libraries were processed according to the pro-
tocol by Tang et al.12. In total, three 8-cell libraries were prepared.
Human ovary poly-A + RNA was obtained from Clontech (cat# 636152). Human ovary cDNA was prepared 
using a first strand cDNA synthesis kit (Invitrogen) according to the manufacturer’s instructions.
PCR primer design. The putative novel transcripts were predicted based on our previous RNAseq data3 and 
these predictions were used for designing PCR cloning primers.
NOBOX primers were designed based on an RNAseq peak at FE518599 (chr7:144100745-144100865,-) 
located in an intron of the human RefSeq sequence NM_001080413.3 (GeneID135935), that was connected to the 
3′ UTR of the predicted sequence. The sequences containing ORFs for CPHX1, CPHX2 and DUXB were predicted 
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based on FE200101 (chr16:75760315-75760435,-), FE200082 (chr16:75710885-75711065,-) and FE200054 
(chr16:75735289-75735420,-), respectively and used for primer design. Predicted sequences used for primer 
design are provided as Supplemental Text S1. TPRX1/TPRX2 primer design was based on prediction for TPRX1 
with an undefined TSS or TFE at chr19:48,307,772-48,307,835 -, and human RefSeq sequence NM_198479.2 
leading to a design of not perfectly matching primers for TPRX2. DUXA, DPRX and ARGFX cloning prim-
ers were designed based on the human RefSeq NM_001012729.1 (NCBI GeneID 503835), NM_001012728.1 
(GeneID 503834) and NM_001012659.1 (GeneID 503582) respectively (Table 1).
Cloning of ARGFX, CPHX1, CPHX2, DPRX, DUXA, DUXB and TPRX2. cDNA libraries from three 
single 8-cell embryos were used for cloning of the putative transcripts. The transcripts were amplified from the 
cDNA libraries using Phusion High-Fidelity DNA polymerase (New England Biolabs) according to the manu-
facturer’s instructions. For amplification of DUXA, DPRX, DUXB, TPRX1 and TPRX2, the following PCR pro-
gram was used: 98 °C for 30 s; 40 cycles of 98 °C for 10 s, 65.9 °C (DUXB)/67.9 °C (DPRX, TPRX1,TPRX2)/71.5 °C 
(DUXA) for 30 s, 72 °C for 1 min; final extension 72 °C for 10 min. ARGFX, CPHX1 and CPHX2 were amplified 
using Touchdown PCR: 98 °C for 30 s; 24 cycles of 98 °C for 10 s, annealing for 30 s, temperature decreasing from 
63 °C to 56 °C, 1 °C/3 cycles, 72 °C for 30 s; 16 cycles of 98 °C for 10 s, 55 °C for 30 s, 72 °C for 30 s; final extension 
72 °C for 10 min. In order to clone the three differently sized TPRX2 isoforms, the PCR products were purified 
from agarose gel using the QIAquick Gel Extraction Kit (Qiagen), and the obtained amplicons were then ream-
plificated in order to obtain sufficient amount of amplicons for subsequent cloning. PCR products were cloned 
into the pCR4Blunt-TOPO vector using the Zero Blunt TOPO PCR Cloning kit (Invitrogen) and verified by 
Sanger sequencing (Eurofins Genomics).
Cloning of NOBOX. Human ovary cDNA was used for cloning putative NOBOX transcript. The tran-
script was amplified from cDNA using HotStarPlus Taq DNA polymerase (Qiagen) according to manufacturer’s 
instructions. For PCR amplification following steps were applied: 95 °C for 5 min; 40 cycles of 95 °C for 30 s, 60 °C 
for 30 s, 72 °C for 1 min; final extension 72 °C for 10 min. PCR product was cloned into pCRII-dual promoter 
TOPO vector using TOPO TA cloning kit (Invitrogen), and sequence was verified by Sanger sequencing (Eurofins 
Genomics).
Prediction of ORFs, functional protein domains, and alignment on UCSC genome browser. For 
open reading frame (ORF) prediction, forward and reverse sequences from each clone were first trimmed for 
vector sequence using Pregap4 version 1.6-r and then the contig sequences were formed using Gap4 v4.11.2-r 
(both from the Staden package, http://staden.sourceforge.net/). Mismatching bases were manually checked for 
quality and edited accordingly. ORFs were predicted and translated using ApE plasmid editor (http://biology-
labs.utah.edu/jorgensen/wayned/ape/). Conserved protein domains were predicted applying an NCBI Blastx 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) translated nucleotide query on each complete clone sequence against 
non-redundant protein sequences (nr) and EMBL-EBI InterPro (http://www.ebi.ac.uk/interpro/) on translated 
sequences. The consensus cDNA and amino acid sequences were aligned by Blat with “psl” as an output (UCSC 
Genome Browser) and the information was combined to generate a BED file for visualization of custom tracks on 
a browser (Supplemental Text S2). The alignments were edited manually in order to include short exons.
Gene expression profiling of hESC lines and single 8-cell blastomeres. A total of 48 single cells were 
manually picked directly to STRT lysis buffer. The cells included 16 human regular ES cells (HS980), 16 human 
single-8-cell blastomere derived ES cells (HS983a) and 16 human single blastomeres from 8-cell embryos. The 
embryos were thawed at 4-cells stage (ThawKit™ Cleave, VitroLife) and cultured in G-1™ Plus media (VitroLife) 
overnight under standard conditions as performed in the IVF Clinic (5% CO2/5%O2). The zona pellucidae were 
removed with Tyrode’s solution (Sigma-Aldrich) and embryos were dissociated into single cells using enzymatic 
(TrypLE, Life technologies) and mechanical separation. The STRT library was prepared according to the modi-
fied STRT protocol (Krjutškov, et al., accepted) and sequenced on four lanes of Illumina HiSeq 2000 instrument. 
Pre-processing of STRT reads, quality control and alignments were performed as previously described (Krjutškov, 
et al., accepted). After quality control, 4 outliers (one regular ES cell, one blastomere-derived ES cell and two 
8-cell blastomeres) were removed from further analysis due to low RNA content. The gene expression was quan-
tified per transcript far 5′ end (TFE) units3. The TFE coordinates for the PRD-like homeobox genes are given in 
Table 1. The reference file for counting the reads per TFE was defined for PRD-like homeobox genes and spike-in 
RNAs only. The reads per TFE were counted using SAMtools version 1.1 and htseq-count version 0.6.1, and the 
data was normalized using external spike-in RNAs as described previously20. The raw read counts and normalized 
expression values for PRD-like homeobox genes and spike-in RNAs used for creating beeswarm plots are given 
in Supplemental Table S3. The original sequence files as well as aligned BAM-files are accessible from European 
Nucleotide Archive (ENA) under the accession number PRJEB12467.
Analysis of methylation pattern for homeobox genes. Publicly available dataset for human sperm, 
preimplantation embryo, ESC and embryonic tissues was downloaded from GEO (accession number GSE51239, 
file hDev100bpMeFinal.txt.gz)18. 100 bp methylation value percentages were used for genomic positions in the 
range of 500 bp up- and downstream from the middle of TFE-s for the homeobox genes.
Publicly available dataset for methylation in human blood cells was downloaded19. The M-values within the 
entire homeobox genes’ region was used.
PCR detection of PRD-like homoebox gene expression. Total RNA extracted from three hESC 
lines (H9, HS401 and HS980) in three biological replicates were used for cDNA synthesis using SuperScript III 
First-Strand Synthesis Supermix for qRT-PCR (Invitrogen) according to the manufacturer’s instructions. For PCR 
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we used an input of 22 ng of cDNA and the reactions were done in three biological replicates. As a control, we 
used 10 ng cDNA from a human 8-cell cDNA library. The PCR reactions were carried out using an ABI PRISM 
7500 Fast Real-Time PCR System with FastStart Universal SYBR Green Master mix (Roche) according to the 
manufacturer’s instructions. The primer sequences are shown in Supplemental Table S4. For validation of the 
amplicons, the PCR products were cloned into a pCRII-dual promoter TOPO vector using the TOPO TA cloning 
kit (Invitrogen), and verified by Sanger sequencing (Eurofins Genomics).
hESC expression vector construction. In order to overexpress ARGFX, CPHX1, CPHX2, DPRX, DUXA, 
DUXB, NOBOX, OTX2 and TPRX2 in mammalian cells, the sequences were cloned into a bicistronic pFastBac 
expression vector. The pFastBac vector was modified as described previously3. Briefly, the transcript sequences 
were amplified from the TOPO vectors using primers containing AscI and PacI restriction sites, digested using 
AscI and PacI (New England Biolabs) and ligated into pFastBac vector. The primer sequences for cloning the 
genes in this study are shown in Supplemental Table S5. mCherry fluorescent protein was used as a control, and 
was amplified from the standard injection marker construct elt-2::GFP for C. elegans (kindly provided by Gert 
Jansen, The Erasmus University Medical Center, Holland). The final structure of the modified expression pFast-
Bac vector was as follows: CMV enhancer – EF1a promoter – AscI – Gene Of Interest – PacI – IRES – eGFP – 
WPRE. The IRES (internal ribosomal entry site) element allows for simultaneous expression of two proteins: the 
inserted gene of interest, and a green fluorescent protein (GFP) marker.
Overexpression experiments and cell sorting for expression profiling. The hESC line HS401 was 
cultured on Laminin-521 (Biolamina) in mTeSR™ 1 media (Stemcell Technologies). One ug of expression vec-
tor containing the gene of interest was incubated with 3 μ l of Lipofectamine2000 in 50 μ l of DMEM. Confluent 
cells (95–100%) were trypsinized, gently washed with DPBS, and re-suspended in 50 μ l of transfection solution. 
The cell suspension was transferred to a new Laminin-521 coated plate with 50 μ l of DMEM and the cells were 
allowed to settle in the transfection solution for 15 minutes. The media was subsequently changed to mTeSR™ 1. 
After 9–11 h of transfection, the cells were washed with DPBS and treated with trypsin to get single-cell solution, 
washed again with DPBS and suspended in ice-cold DPBS until the analysis. The overexpression time point was 
chosen by time-course analysis using pFastBac-mCherry vector and further estimation when the first wave of 
target genes would be expressed. Cell viability was assessed by 1:1000 propidium iodide (Molecular Probes) and 
cell clusters were removed by FSC and SSC. 75 cells per sample from GFP positive and GFP negative cells were 
sorted in three replicates into 5 μ l of library lysis buffer. The sorting was performed in three replicas from the same 
transfection well for 75 transfected and 75 non-transfected cells in each replica (altogether 6 samples per gene) for 
each gene and mCherry control (n = 9), providing two libraries for pooled sequencing of 54 samples by modified 
STRT protocol (Krjutškov, et al. accepted).
The homeobox genes were distributed between two libraries that were processed simultaneously. The first of 
these, Library 3, included DUXA, DPRX, ARGFX, OTX2 and mCherry. The second library, Library 4, included 
CPHX1, CPHX2, DUXB, TPRX1, NOBOX and mCherry.
STRT RNAseq analysis for target gene detection. The STRT data was analyzed as described previ-
ously3. Briefly, the reads were filtered, de-multiplexed by barcodes, joined for the same unique molecular iden-
tifiers (UMI), trimmed for the barcodes and UMI-s, and mapped to the human UCSC genome hg19 by TopHat. 
Outliers were identified by analysis of distance correlation dendrograms, which indicated two outliers for one 
library (Library 3, Supplementary Figure S12a) and no outliers for the second library (Library 4, Supplementary 
Figure S12b). The outlier E8 in Library 3 (mCherry, GFP negative) was removed, resulting in one library having 
one less GFP negative control. The principal components one and two separated two different DPRX wells from 
the controls, and the components 3 and 4 separated none, therefore DPRX was not removed.
The signal of STRT sequencing forms clusters that were identified as Transcript Far 5′ End (TFE) as described 
previously (Krjutškov, et al. accepted). Briefly, the aligned BAM files were assembled into putative transcripts by 
sample types using Cufflinks, followed by extraction of only the 5′ -end exons by UCSC tools and followed by 
merging reads from various sample types by BEDTools. The reads were counted on the identified TFE-s by htseq.
The raw reads were aligned by TopHat to the modified pFastBac backbone vector, and reads counted by htseq, 
in order to confirm overexpression in the GFP positive versus GFP negative cells.
Three sets of controls were used for performing differential analysis: only mCherry control GFP positive 
wells (n = 3), only GFP-negative wells from the whole library (n = 22 or n = 23), and the combination of both 
mCherry control and homeobox specific GFP-negative wells (n = 3 + 3). Estimates of differential expression for 
the TFE-s were obtained using the R package SAMstrt with positive samples compared to each of the three 
control (FDR < 0.05 unless indicated otherwise)20. Only intersection of the differentially expressed TFE-s from 
three analysis was used in the study. The identifier TFE-s were mapped to the genome and annotated for genes 
and genomic regions as described previously3. Only the reads mapping to 5′ UTR of coding genes were used in 
the study.
The original sequence files as well as aligned BAM-files are accessible from ENA by the accession number 
PRJEB12453.
Gene expression analysis for public preimplantation datasets. Three publicly available datasets 
were used for gaining differentially expressed genes lists. Two independent studies were used for gaining the EGA 
genes lists2,3. The TFE identifiers up-regulated by either 4- or 8-cell stage were gained from Töhönen et al. and the 
identifiers were matched with at least 1 bp overlap by BEDTools.
The RPKM values were downloaded from Yan et al. and up-regulated genes by either 4- or 8-cell stage were 
calculated by students t-test (FDR < 0.05). Only gene names that had a match in our dataset were used for the 
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analysis. Average RPKM values in Oocytes, Zygotes, 2-, 4-, 8-cell embryos, Morluae, Epiblast and passage 0 ESC-s 
were used for calculating the gene expression levels of up-regulated target genes.
Raw count values were downloaded from a study that performed RNA sequencing on different lineages of 
human blastocysts22. Students t-test was done for four comparisons in order to obtain genes specifically expressed 
in TE (TE vs EPI), ICM (EPI vs TE), PE (PE vs EPI) and EPI (EPI vs PE). Ensembl ID-s for the differentially 
expressed genes (p < 0.05) were converted to the associated gene names by Ensembl Biomart tool35 and intersect-
ing gene names with our dataset were used.
The number of intersecting identifiers present in both datasets, not present in either one or both of the datasets 
were calculated for the Chi-squared test.
Motif analysis. The MAST tool23 was used to search for significant sequence patterns to all given motifs 
in a gene set. Sequences − 2000 and + 500 bp from the center of each TFE for differentially regulated genes 
(FDR < 0.1) were analyzed. A list of all transcription start sites was gained from FANTOM database, and used as 
a control set to the THE-s.
Luciferase reporter assay. HEK-293 cells (ATCC) were seeded on 48-well plates in DMEM containing 1 g/l 
glucose, L-glutamine, pyruvate and supplemented with 10% FBS and 2 mM L-glutamine (all from Gibco). Cells 
were grown overnight at 37 °C in 5% CO2 and transfected with the ZSCAN4 promoter in pGL4.25 reporter vector 
described previously3 or pGL4.25 luciferase vector (Promega) in combination with CPHX1, CPHX2 or ARGFX, 
all cloned into pFastBac vector as described above. Renilla luciferase vector pGL4.74 [hRluc/TK] (Promega) 
was co-transfected with other constructs to enable normalization. The concentrations for single constructs were 
as follows: Luciferase vector 100 ng/well, pFastBac vector 100 ng/well and Renilla luciferase vector 10 ng/well. 
The transfections were performed using Lipofectamine 2000 (Invitrogen) 0.5 μ L/well according to manufactur-
er’s instructions. Cells were incubated at 37 °C in 5% CO2, harvested 24 h after transfection and subjected to 
Dual luciferase assay (Promega) in three biological replicates with two technical replicates each, according to 
manufacturer’s protocol. Luciferase signals were measured using a TECAN infinite M200 (Tecan, Männedorf, 
Switzerland).
Data availability statement. All the novel homeobox genes clone sequences were submitted to EMBL, 
and their ENA accession numbers are given in Fig. 1. The short read sequences and aligned BAM-files from 
the RNA-seq experiments for the overexpression in ES-cells are uploaded in ENA with the accession number 
PRJEB12453. The RNA-seq dataset from single-cell hESC-s and 8-cell human embryo have the accession number 
PRJEB12467.
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